Does TESAMORELIN Cause Product dose omission issue? 277 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 277 reports of Product dose omission issue have been filed in association with TESAMORELIN (EGRIFTA SV). This represents 11.5% of all adverse event reports for TESAMORELIN.
277
Reports of Product dose omission issue with TESAMORELIN
11.5%
of all TESAMORELIN reports
0
Deaths
13
Hospitalizations
How Dangerous Is Product dose omission issue From TESAMORELIN?
Of the 277 reports, 13 (4.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TESAMORELIN. However, 277 reports have been filed with the FAERS database.
What Other Side Effects Does TESAMORELIN Cause?
Arthralgia (188)
Injection site pain (186)
Incorrect dose administered (167)
Drug ineffective (159)
Weight increased (138)
Injection site bruising (134)
Peripheral swelling (126)
Pain in extremity (121)
Product preparation issue (119)
Injection site pruritus (117)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TESAMORELIN Alternatives Have Lower Product dose omission issue Risk?
TESAMORELIN vs TESTOSTERONE
TESAMORELIN vs TESTOSTERONE CYPIONATE
TESAMORELIN vs TESTOSTERONE ENANTHATE
TESAMORELIN vs TESTOSTERONE UNDECANOATE
TESAMORELIN vs TETANUS TOXOIDS